d
Global FinanceAsset-backed securities and derivatives
Collateralized loan obligations
Commercial mortgage-backed securities
Commercial real estate finance
Fund finance
Leveraged finance
Life sciences finance
Residential mortgage finance
Special situations
2
Clients turn to Dechert for practical commercial judgment across regions and requirements. We provide wide-ranging services for complex financings with a focus on sophisticated and efficient deal structuring and execution.
Our global finance team advises on corporate finance, leveraged finance, real estate finance, structured finance and
securitization matters. By tapping into the breadth of Dechert’s expertise – including tax, ERISA, investment company
matters, securities, derivatives and bank regulatory matters – we deliver comprehensive solutions for all of your
finance needs.
Attorney advertising. Prior results do not guarantee a similar outcome.
2,000+ FINANCE TRANSACTIONS IN THE PAST TWO YEARS
40+ COUNTRIES WHERE WE HAVE FINANCE EXPERIENCE
1 SEAMLESS PRACTICE
130+ FINANCE LAWYERS WORLDWIDE
3
A globally recognized leader
Named “Law Firm of the Year – Americas” in the PDI Awards for Dechert’s outstanding work on a host of transactions and financings.
PRIVATE DEBT INVESTOR 2017
Ranked nationally in the U.S. for Capital Markets: Securitization and as a leading firm in London for Securitisation.
CHAMBERS AND PARTNERS 2006-2017
Named “Best Law Firm for CLOs.”
GLOBALCAPITAL SECURITIZATION AWARDS 2014-2017
Ranked for Commercial Lending: Advice to Borrowers and Advice to Lenders and Real Estate Law in the U.S., and for Real Estate Finance and Securitisation in London.
THE LEGAL 500 2015-2017
Ranked in the U.S. for Banking and Finance Law.
IFLR1000 2017
One of only two firms in 2016 named a top 10 most innovative law firm in both Europe and North America.
FINANCIAL TIMES 2016
4
A full range of financing capabilities
Commercial mortgage-backed securities (CMBS)
Dechert’s team has been involved in the bulk of CMBS ever issued. We advise issuers, underwriters, collateral managers, IG
and B-piece investors in CMBS, CDOs/CLOs, Re-REMICs, NPLs and other alternate securitized structures involving commercial
real estate and residential mortgages.
B-piece and
investors
Conduits,
floaters and
CRE CLOs
Issuer and
underwriterRisk retention Servicing
Workout and
restructuring
Asset-backed securities and derivatives
Dechert has extensive experience advising clients on large, complex securitization and structured finance transactions across a
wide variety of asset classes and complex securitization structures.
Consumer
assetsDerivatives Esoterics Risk retention
Trade and
equipment
receivables
Warehouse,
repo and term
financing
Collateralized loan obligation (CLOs) and loan securitization
With Dechert’s broad experience we have earned a market-leading position in the representation of issuers, placement agents,
collateral managers and equity investors in CLO transactions. In addition to CLOs, we assist asset managers seeking to finance
their loan origination activity using bank leverage and securitization technology.
Arbitrage CLOsBalance sheet
CLOs
Collateralized
debt obligation
Middle-market
CLOs
Risk retention
capital
formation
5
Commercial real estate finance
Dechert is a leader in commercial real estate finance. We represent clients on the purchase and sale of commercial real estate
debt products. We also have extensive experience advising clients on the origination of the commercial real estate loans that
occur prior to purchase/sale and throughout the full life cycle of commercial real estate loans after origination.
Construction
finance
Mezzanine and
B-notes finance
Mortgage
finance
Warehouse and
repos
Fund finance
Dechert advises clients on all aspects of funds finance, including providing financial institutions, alternative lenders and asset
managers with input on debt and leverage issues at the time of fund formation and downstream structuring and transactions.
We deliver effective deal structuring and execution, drawing on a deep understanding of fund structures and the financing
options available to fund entities.
ABL, term and
structured term
facilities
Redemption
facilities
Repos/
derivatives
Subscription
finance
Subscription/
capital call
facilities
Leveraged finance
With experienced finance lawyers in the U.S., Europe, the Middle East and Asia, Dechert represents a broad spectrum of asset
managers, private equity sponsors and lenders, including banks and alternative capital providers, in a wide range of domestic
and cross-border financing transactions and debt restructurings.
Financing
to and by
alternative
capital
providers
Financing
to and by
private equity
and other
investment
funds
Private equity/
acquisition
finance
Strategics/
corporate
finance
6
A full range of financing capabilities
Residential mortgage finance
Dechert is at the forefront of residential mortgage loan acquisitions, servicing and residential mortgage-backed securities
(RMBS). Our lawyers have represented issuers, underwriters, servicers and investors in post-credit crisis RMBS transactions.
Dechert represents both buyers and sellers of pools of performing mortgage loans, non-performing mortgage loans and REO.
As counsel to mortgage servicers, Dechert advises on a wide variety of matters, including compliance with Regulation AB
requirements and the establishment of procedures necessary to comply with securitization servicing standards.
Issuer and
underwriter Mortgage loans Servicing
Structuring for
hedge fund and
private equity
investors
Warehouse and
repo financing
Life sciences finance
As part of Dechert’s market-leading life sciences industry group, our global finance lawyers advise on the full range of finance
transactions on behalf of new and established life sciences companies. We work closely with these companies to capture and
structure the capital they need to support the long development and commercialization process, ranging from early-stage
venture financings and venture debt to more innovative transactions such as royalty monetization and drug development
financing strategies used to accelerate growth and to manage balance sheet risk. We also have experience advising both
companies and lenders on a wide range of convertible, senior debt, acquisition-related and other life sciences industry
financing transactions.
Convertibles
Drug
development
financing
Royalty
monetizationsSenior debt Venture debt
7
Special situations
Dechert’s integrated, cross-practice approach to special situations allows us to provide exceptional finance, corporate, funds/
regulatory and commercial litigation advice to our distressed debt fund clients in workouts and in recovery and transactional risk
assessments.
Consensual
restructurings/
workouts
Equity
structures
Funds and
regulatory
expertise
Commercial
litigation
Debt recovery
and
transactional
risk
assessments
for trading and
arbitrage
opportunities
Additional capabilities
Bankruptcy CTL financeEquipment
financing
International
and domestic
tax
Investment
company-related
finance
Project
financing
8
CRE funds – Aberdeen
– Annaly
– Ares
– BlackRock
– Blackstone
– CommerzReal
– Ellington
– First Key
CRE issuers – A10 Capital
– Ares
– Bancorp
– Bank of America
– CCRE
– Citibank
– Resource America
CRE lenders – Barclays
– Bank of America
– Citigroup
– Goldman Sachs
– Macquarie Bank
– MetLife
– Morgan Stanley
CRE underwriters – Barclays
– Bank of America
– CCRE
– Citibank
– Credit Suisse
– Goldman Sachs
– Wells Fargo
Asset-backed lenders – Bank of America
– Barclays
– Citigroup
– Credit Suisse
– Guggenheim
– Perella Weinberg
– Rabobank
B-Piece buyers/investors – Blackstone
– CBRE
– Ellington
– Elliott Capital
– KKR
– Prima Capital
BDCs – Alcentra Capital
Corporation
– Corporate Capital Trust I and II
– Crescent Capital BDC
– FS Investment Corporation
– Goldman Sachs BDC
– Golub Capital
– PennantPark
CLO bankers and sponsors – Apollo
– Crescent Capital
– Golub Capital
– Guggenheim
– Morgan Stanley
– Octagon
Representative clients
9
Public and private funds – Alliance Bernstein
– Apollo
– Crescent Capital
– KKR Income Opportunities Fund
– Providence Equity
– TIAA
Servicers (master and special) – Berkadia
– Blackstone
– CBRE Capital Partners
– Midland
Warehouse lenders – Bank of America
– Barclays
– Citi
– Goldman Sachs
– Macquarie Bank
– Wells Fargo
Distressed debt funds – Elliott Advisors
– Rimrock Alternative Capital
– Aurelius Capital Management
– Q Investments
– Monarch Alternative Capital
– Stonehill Capital
– King Street Capital Management
Leveraged finance lenders – Ares
– Credit Suisse
– Fifth Street
– GarMark Partners
– ING
– Main Street Capital
– Prospect Capital
– Sumitomo
– THL Credit, Inc.
Life sciences companies – Celgene Corporation
– Edge Therapeutics
– Egalet
– Forward Pharma
– Johnson & Johnson
– Lysogene
– Progenics Pharmaceuticals
– Zealand Pharma
Private equity firms – Bregal Partners
– Centre Partners Management
– Court Square Capital Partners
– GIC
– Graham Partners
– Mid Europa Partners
– One Equity Partners
– Sterling Investment Partners
10
Our global finance group is the choice of market makers for innovative structures, creative financing strategies and complex transactions.
A diverse client base
Private equity
sponsors and
hedge funds
Money center
and commercial
banks
Real estate
funds
Life insurance
companies
Distressed
debt funds
Debt
funds
Life sciences
companiesREITs
Pension
vehicles
Business
development
companies
(BDCs)
Sovereign
entities
Investment
trusts (UK)
Other
alternative
capital providers
Other
permanent
capital vehicles
Advising clients around the worldAs part of a global law firm with offices throughout the United States, Europe, Asia and the Middle East, Dechert’s
global finance practice provides comprehensive services to our clients wherever they do business.
About DechertDechert is a global law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients’ most important matters. Nothing stands in the way of giving clients the best of the firm’s entrepreneurial energy and seamless collaboration.